GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 783 filers reported holding GLAXOSMITHKLINE PLC in Q2 2017. The put-call ratio across all filers is 0.75 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $3,942,000 | +22.6% | 90,561 | +22.7% | 0.11% | +23.3% |
Q1 2022 | $3,216,000 | +24.2% | 73,836 | +7.3% | 0.09% | -55.9% |
Q3 2020 | $2,590,000 | -83.4% | 68,799 | -82.0% | 0.20% | -81.8% |
Q2 2020 | $15,627,000 | -24.4% | 383,105 | -12.9% | 1.12% | -29.6% |
Q4 2019 | $20,679,000 | +35.5% | 440,066 | +23.1% | 1.59% | -16.2% |
Q3 2019 | $15,256,000 | +33.1% | 357,455 | +24.8% | 1.90% | +32.1% |
Q2 2019 | $11,461,000 | +438.1% | 286,370 | +461.8% | 1.44% | +304.2% |
Q1 2019 | $2,130,000 | -19.8% | 50,971 | -22.6% | 0.36% | +22.3% |
Q2 2018 | $2,655,000 | +0.9% | 65,869 | -2.2% | 0.29% | -16.6% |
Q1 2018 | $2,631,000 | -44.9% | 67,350 | -50.0% | 0.35% | +14.1% |
Q4 2017 | $4,776,000 | +352.3% | 134,656 | +449.6% | 0.31% | +393.5% |
Q2 2017 | $1,056,000 | +34.5% | 24,499 | +26.6% | 0.06% | -17.3% |
Q1 2016 | $785,000 | -67.9% | 19,351 | -66.2% | 0.08% | -82.3% |
Q4 2014 | $2,447,000 | – | 57,258 | – | 0.42% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
OSTERWEIS CAPITAL MANAGEMENT INC | 1,948,915 | $79,029,000 | 4.59% |
Chubb Ltd | 400,000 | $16,220,000 | 4.42% |
Pegasus Partners Ltd. | 172,275 | $6,986,000 | 3.79% |
Keystone Financial Planning, Inc. | 117,762 | $4,775,000 | 3.42% |
P.R. Herzig & Co. Inc. | 36,950 | $1,498,000 | 3.28% |
Sterneck Capital Management, LLC | 112,535 | $4,563,000 | 3.21% |
Hamlin Capital Management, LLC | 1,454,031 | $58,961,000 | 2.98% |
Healthcare Value Capital, LLC | 50,000 | $2,028,000 | 2.98% |
Jolley Asset Management, LLC | 80,639 | $3,270,000 | 2.98% |
JFB Holdings Corp | 2,415,570 | $97,951,000 | 2.91% |